Lumos Diagnostics FY22 First Half Year Results
Filed with ASX ·
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call6ix hasn’t read this filing yet.
Lumos Diagnostics Holdings Ltd. on 6ix
Earlier from Lumos Diagnostics
- Change To Lumos Board
- Victorian Government Intent for Lumos Manufacturing Hub
- Over 100 Pharmacies in Liverpool UK Launch FebriDx Service
- Lumos Provides ViraDx and FebriDx Regulatory Update
- Lumos Receives Initial Orders for CoviDx In Canada
Later from Lumos Diagnostics
- FY2022 Half Year Update
- FebriDx Update - Brazil Market Authorisation & New Study
- Operational Review & Management Reorganisation
- Operational Update and Accelerated Entitlement Offer
- Target Market Determination
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics